Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 CA014520, P50 DE026787, 1DP5OD024576, U01CA233102
NCI NIH HHS
Grant: U01 CA233102
NCATS NIH HHS
Grant: TL1 TR002375
NIH HHS
Grant: DP5 OD024576
NIGMS NIH HHS
Grant: T32 GM008692
NIDCR NIH HHS
Grant: P50 DE026787
NCI NIH HHS
Grant: P30 CA014520
National Institutes of Health
Grant: 5TL1TR002375-04
NRSA Training Core
National Institutes of Health
Grant: 5P50DE026787-02
Head and Neck Cancer SPORE at the University of Wisconsin
National Institutes of Health
Grant: 5U01CA233102-04
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
National Institutes of Health
Grant: 5DP5OD024576-02
Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination
National Institutes of Health
Grant: 5T32GM008692-22
Integrated Training For Physician-Scientists
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
FWCI
1.75
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals